We focus on niche therapeutic areas of CNS, ARVs, and Controlled substances. We specialize in CNS segments like ADHD, Anti-psychotics, Anti-vertigo, Anti-inflammatory, Pain management, Alzheimer’s disease, and others. We are moving up the value chain by adding the capacities for APIs and other high-growth therapeutic areas like Anti-diabetic, Anti-coagulants, and others.
